Skip to main content
鹿得医疗 logo

鹿得医疗 — Investor Relations & Filings

Ticker · 920278 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2022-01-05 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920278

About 鹿得医疗

https://www.asian-medical.com/

Jiangsu Lude Medical Device Co., Ltd. specializes in the research, development, and manufacturing of home medical diagnostic and respiratory care equipment. The company's core product portfolio includes mechanical and electronic sphygmomanometers, stethoscopes, nebulizers, and digital thermometers. It focuses on providing high-precision instruments for chronic disease management and home healthcare. With a strong emphasis on technical innovation and quality control, the firm maintains various international quality certifications to support its global OEM and ODM service capabilities. Its products are designed to meet the needs of both professional medical environments and domestic health monitoring, emphasizing accuracy, reliability, and user-friendly operation in the field of physiological parameter measurement.

Recent filings

Filing Released Lang Actions
第三届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed resolution record from the third board of directors' tenth meeting of Jiangsu Lude Medical Electronics Co., Ltd. It includes meeting attendance, agenda items, voting results, and references to various company governance documents and policies. The content focuses on board decisions, amendments to company bylaws, management rules, and financial usage plans, with multiple mentions of submission to shareholders for approval. There is no presentation of financial statements or financial performance data, nor is it a transcript of a call or an announcement of voting results. The document is a formal record of board meeting decisions and governance matters, fitting the category of Board/Management Information (MANG). The document length is substantial and contains detailed board resolutions, not just an announcement or summary, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2022-01-05 Chinese
2022年第一次临时股东大会通知公告(更正公告)
Regulatory Filings Classification · 95% confidence The document is a correction announcement related to a previously issued notice about convening an extraordinary general meeting of shareholders. It references the company's shareholder meeting system and legal compliance but does not contain financial data, management discussion, or detailed report content. The document is short (793 characters) and serves to correct and clarify a prior announcement. It is not a report itself but an announcement related to shareholder meeting notices. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-01-05 Chinese
2022年第一次临时股东大会通知公告
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2022 first extraordinary general meeting of shareholders (临时股东大会) for Jiangsu Lude Medical Electronics Co., Ltd. It details the meeting date, voting methods, agenda items to be discussed, registration procedures, and other logistical information. It does not contain actual financial statements or detailed financial analysis. The document is primarily an announcement of a shareholder meeting and the matters to be voted on, rather than the meeting materials or results themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is over 6000 characters, indicating it is not a brief report publication announcement. Hence, the classification is AGM-R with high confidence.
2022-01-05 Chinese
2021年度被认定为江苏省专精特新小巨人企业的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (679 characters) from Jiangsu Lude Medical Electronics Co., Ltd. stating that the company has been recognized as a "Specialized, Refined, Distinctive and Innovative" (专精特新) small giant enterprise by the Jiangsu Provincial Department of Industry and Information Technology. It includes a reference to the official notification document and discusses the positive impact of this recognition on the company. There are no financial statements, no detailed financial data, no earnings information, no management discussion, or other report content. The document is an official announcement of a recognition or award, not a financial or regulatory report. It is also not a report publication announcement since it does not mention any report being attached or published. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-01-04 Chinese
独立董事工作细则
Governance Information Classification · 95% confidence The document is titled '独立董事工作细则' which translates to 'Independent Director Work Rules'. It details the governance structure, qualifications, rights, obligations, and management of independent directors in the company. It references relevant laws and regulations, including the Company Law, Securities Law, and Beijing Stock Exchange listing rules. The content is focused on governance practices and internal rules related to board members, specifically independent directors. There is no financial data, audit information, or report publication mentioned. The document is a governance-related policy document rather than a financial report or announcement. Therefore, the most appropriate classification is Governance Information (CGR). The document length (6021 characters) supports it being a full policy document rather than a brief announcement.
2022-01-03 Chinese
利润分配管理制度
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement of the company's profit distribution management system, including policies on dividends, cash and stock dividends, procedures for approval, and supervisory mechanisms. It is a formal disclosure by the board of directors, dated January 4, 2022, and references compliance with laws and stock exchange rules. The document does not contain financial statements or results but rather outlines the rules and policies for profit distribution and dividend payments. It is not an annual or interim report, earnings release, or any financial statement. It is also not a proxy solicitation or voting results announcement. Given the nature of the document as a formal policy announcement related to dividend distribution and shareholder returns, it fits best under the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related details for shareholders. The document is under 5,000 characters but contains substantive policy content rather than just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the most appropriate classification is DIV with high confidence.
2022-01-03 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.